|
Envelope surface glycoprotein gp120
|
env
|
The transcription factors and kinases c-Jun, JNK, MEK, p38 MAPK, STAT-3, JAK-1, TFII D, TFII F, eIF-4E, and RNA polymerase II are induced by HIV-1 gp120 |
PubMed
|
|
Nef
|
nef
|
HIV-1 Nef expression in primary T cells upregulates MEK1/2 activities, which induces the increased phosphorylation of ERK1/2 |
PubMed
|
|
Tat
|
tat
|
HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat |
PubMed
|
|
tat
|
HIV-1 Tat-mediated upregulation of ICAM-1 expression involves MEK1/2, JNK, and p38 MAPK proteins and downstream IKK2/NF-kappaB signaling pathways |
PubMed
|
|
tat
|
Tat and IFN-gamma synergistically induce the expression of CXCL10, which is inhibited by MEK1/2 inhibitor and the p38 mitogen-activated protein kinase (MAPK) inhibitor |
PubMed
|
|
tat
|
MAP2K2 is downregulated in HIV-1 Tat and NC cotransfection of HEK 293T cells |
PubMed
|
|
tat
|
HIV-1 Tat activates mitogen-activated protein kinases ERK1 and ERK2 through the activation of MEK1 and MEK2, leading to induction of IL-8, IL-10, IP-10, iNOS, superoxide and TNF-alpha, as well as the activation of CREB and increased albumin permeability |
PubMed
|
|
Vpr
|
vpr
|
Inhibition of MEK1,2 impairs HIV-1 Vpr-induced BID cleavage |
PubMed
|
|
vpr
|
Overexpression of HIV-1 Vpr decreases phosphorylation of MEK2 |
PubMed
|
|
vpr
|
HIV-1 Vpr downregulates expression of genes involved in the MEK2-ERK pathway, including MAP2K2 (MEK2) and MKNK2 |
PubMed
|
|
nucleocapsid
|
gag
|
Mitogen-activated protein kinase kinase 2 (MAP2K2) is downregulated in HIV-1 Tat and NC cotransfection of HEK 293T cells |
PubMed
|